Similarly, [64Cu]DOTA-trastuzumab visualized HER2-positive metastatic breast cancer with high precision thus providing valuable information for selection of patients that could benefit by HER2-targeted treatments [30,31]. Here, ERBB2 is linked to breast cancer.